• 1
    Schipper H, Clinch J, Powell V. Definitions and conceptual issues. In: Spilker, B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Lippincott- Raven Publishers, Philadelphia, 1996, 1123.
  • 2
    Stewart AL, Hays R, Ware JE. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988;26:724732.
  • 3
    Rutten-van Molken MPMH, Clusters F, Van Doorslaer EKA et al. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 1995;8:888898.
  • 4
    Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exper Allergy 1991;21:7783.
  • 5
    Von Neumann J, Morgenstern O. Theory of Games and Economic Behavior. Wiley, New York, 1953.
  • 6
    Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econom 1986;5:130.
  • 7
    Juniper EF, Guyatt GH, Feeny DH, Griffith LE, Ferrie PJ. Minimum skills required by children to complete health-related quality of life instruments. comparison of instruments for measuring asthma-specific quality of life. Eur Respir J 1997;10:22852294.
  • 8
    Juniper EF, Norman GR, Cox FM, Roberts JN. Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma. Eur Respir J 2001;18:3844.
  • 9
    Torrance GW. Utility approach to measuring health-related quality of life. J Chron Dis 1987;40:593600.
  • 10
    Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 1996;98:843845.
  • 11
    Guyatt GH, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurement properties? J Clin Epidemiol 1992;45:13411345.
  • 12
    Guyatt GH, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chron Dis 1987;40:171178.
  • 13
    Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the Mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exper Allergy 2000;30:132140.
  • 14
    Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial rhinitis with the French version of the SF-36 health status questionnaire. J Allergy Clin Immunol 1994;94:182188.
  • 15
    Bousquet J, Duchateau J, Pignat JC, et al. Improvement of quality of life by treatment with citirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. J Allergy Clin Immunol 1996;98:309316.
  • 16
    Feeny D, Furlong W, Barr RD, Torrance GW, Rosenbaum P, Weitzman S. A comprehensive multi-attribute system for classifying the health status of survivors of childhood cancer. J Clin Oncol 1992;10:923928.
  • 17
    The Euroqol Group. A new facility for the measurement of health-related quality of life. Health Policy 1990;16:199208.
  • 18
    Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS. Interpreting treatment effects in randomised trials. Br Med J 1998;316:690693.
  • 19
    Johansson SGO, Hourihane JO'B, Bousquet J et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813824.
  • 20
    De Graff-In't Veld T, Koenders IM, Garrelds IM, Gerth van Wijk R. The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis. J Allergy Clin Immunol 1996;98(3):508513.